PrognostX Health, Inc (previously AmDx PrognostX, Inc)

PrognostX Health, Inc (previously AmDx PrognostX) is a health and human services biotechnology company that focuses on the development and commercialization of clinical diagnostics for diabetes, chronic kidney disease, cardiovascular disease, cerebrovascular disease, and Alzheimers disease. The company also consults with universities and biotechnology, diagnostic testing, and biopharmaceutical companies. PrognostX Health is launching one of its clinical diagnostic tests in 2024 and initiating clinical trials for FDA approval.